Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether telmisartan and/or a low-glycemic index
diet are effective in reducing intra-myocellular lipid (muscle fat) content.
Phase:
Phase 3
Details
Lead Sponsor:
McMaster University
Collaborators:
Boehringer Ingelheim Canadian Institutes of Health Research (CIHR) Heart and Stroke Foundation of Canada Medtronic